title: The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes.
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Pruneri
authors.forename: Nicola
authors.initials: N
authors.lastname: Fracchiolla
authors.forename: Agostino
authors.initials: A
authors.lastname: Cortelezzi
authors.forename: Maurilio
authors.initials: M
authors.lastname: Ponzoni
authors.forename: Patrick
authors.initials: P
authors.lastname: Maisonneuve
authors.forename: Giorgio
authors.initials: G
authors.lastname: Lambertenghi-Deliliers
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D019927:Cyclin E / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000378:metabolism* / Q000401:mortality; D015995:Prevalence; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis*; D015996:Survival Rate
chemical_list: D015415:Biomarkers; D019927:Cyclin E; D018809:Proliferating Cell Nuclear Antigen; C413374:p27 antigen